Trial · NCT03457701
Results by group106
Each measurement the trial posted, group by group, in the words and numbers it posted.
41 to 60 of 106
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Periods 1 and 2: Ratio to Baseline in Ferritin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 28 | 1.278 | Geometric Coefficient of Variation 53.1128 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline in Ferritin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 28 | 0.911 | Geometric Coefficient of Variation 23.5414 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 14 | 0.860 | Geometric Coefficient of Variation 86.4844 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 14 | 0.904 | Geometric Coefficient of Variation 52.1384 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 28 | 0.916 | Geometric Coefficient of Variation 61.2898 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 28 | 1.052 | Geometric Coefficient of Variation 27.7868 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 14 | 0.703 | Geometric Coefficient of Variation 74.4694 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 14 | 1.201 | Geometric Coefficient of Variation 63.6067 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 28 | 0.802 | Geometric Coefficient of Variation 73.5598 | Microgram per liter (ug/L) |
| Periods 1 and 2: Ratio to Baseline (Day 1) in Hepcidin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 28 | 1.306 | Geometric Coefficient of Variation 47.6931 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 14 | 0.135 | Standard Deviation 0.3086 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 14 | -0.062 | Standard Deviation 0.1824 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 28 | 0.075 | Standard Deviation 0.2544 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 28 | -0.090 | Standard Deviation 0.1380 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 14 | 0.063 | Standard Deviation 0.2225 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 14 | -0.068 | Standard Deviation 0.2405 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 28 | 0.032 | Standard Deviation 0.3578 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Erythroferrone Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 28 | -0.110 | Standard Deviation 0.2278 | Microgram per liter (ug/L) |
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 14 | 0.7 | Standard Deviation 3.67 | Grams per liter (g/L) |
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 14 | 2.8 | Standard Deviation 2.99 | Grams per liter (g/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03457701/results?page=3